Alexa Wonnacott
Impact in
- Nephrology top 2%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Acute Kidney Injury Research 3
- Chronic Kidney Disease and Diabetes 2
-
- RNA regulation and disease 2
- Extracellular vesicles in disease 2
- Co-authors
- Aled O. Phillips (5 shared papers)Soma Meran (5 shared papers)Bethan Amphlett (2 shared papers)Bnar Talabani (2 shared papers)Donald Fraser (5 shared papers)Timothy Bowen (4 shared papers)Kate Simpson (3 shared papers)Apexa Kuverji (2 shared papers)
- Journals
- Advanced Drug Delivery Reviews (1 paper)EClinicalMedicine (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)Nephrology (1 paper)Clinical Kidney Journal (1 paper)
- Partner nations
- United KingdomSweden
In The Last Decade
Alexa Wonnacott
12 papers receiving 575 citations
Peers
Comparison fields: 5 of 70
- Nephrology 257
- Cancer Research 120
- Critical Care and Intensive Care Medicine 28
- Endocrinology, Diabetes and Metabolism 71
- Emergency Medicine 19
Countries citing papers authored by Alexa Wonnacott
This map shows the geographic impact of Alexa Wonnacott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa Wonnacott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa Wonnacott more than expected).
Fields of papers citing papers by Alexa Wonnacott
This network shows the impact of papers produced by Alexa Wonnacott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa Wonnacott. The network helps show where Alexa Wonnacott may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexa Wonnacott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 214 | |
| 2 | 2016 | 119 | |
| 3 | 2018 | 66 | |
| 4 | 2021 | 43 | |
| 5 | 2023 | 40 | |
| 6 | 2021 | 31 | |
| 7 | 2006 | 25 | |
| 8 | 2014 | 21 | |
| 9 | 2015 | 18 | |
| 10 | 2012 | 4 | |
| 11 | 2019 | 3 | |
| 12 | 2012 | 1 | |
| 13 | 2023 | 0 | |
| 14 | 2013 | 0 |
About Alexa Wonnacott
Alexa Wonnacott is a scholar working on Nephrology, Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research and Infectious Diseases, having authored 14 papers that have together received 585 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Diabetes Treatment and Management (3 papers), Acute Kidney Injury Research (3 papers), Cancer-related molecular mechanisms research (3 papers), Chronic Kidney Disease and Diabetes (2 papers), RNA regulation and disease (2 papers), Extracellular vesicles in disease (2 papers) and Hormonal Regulation and Hypertension (1 paper). The work is most often cited by research in Nephrology (257 citations), Cancer Research (120 citations), Critical Care and Intensive Care Medicine (28 citations), Endocrinology, Diabetes and Metabolism (71 citations) and Emergency Medicine (19 citations). Alexa Wonnacott has collaborated with scholars based in United Kingdom and Sweden. Frequent co-authors include Aled O. Phillips, Soma Meran, Bethan Amphlett, Bnar Talabani, Donald Fraser, Timothy Bowen, Kate Simpson, Apexa Kuverji, William G. Herrington and Laura Denby. Their work appears in journals such as Advanced Drug Delivery Reviews, EClinicalMedicine, Clinical Journal of the American Society of Nephrology, Nephrology and Clinical Kidney Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.